Bristol-Myers Squibb (BMY) to Sell Global Diabetes Business in $4.3B+ Deal (AZN)
Tweet Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) announced that it has signed an agreement to sell its global diabetes business that was ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE